Hill R, Fok M, Grundy G, Parsons J, Rocha S
Radiother Oncol. 2023; 189:109951.
PMID: 37838322
PMC: 11046710.
DOI: 10.1016/j.radonc.2023.109951.
Zhou R, Zhao D, Beeraka N, Wang X, Lu P, Song R
Metabolites. 2022; 12(10).
PMID: 36295845
PMC: 9612299.
DOI: 10.3390/metabo12100943.
Obata S, Ishimaru Y, Miyagi S, Nakatake M, Kuroiwa A, Ohta Y
Mol Clin Oncol. 2022; 16(3):68.
PMID: 35154708
PMC: 8822901.
DOI: 10.3892/mco.2022.2501.
Singh A, Dashnyam M, Chim B, Escobar T, Dulcey A, Hu X
Sci Rep. 2020; 10(1):3766.
PMID: 32111885
PMC: 7048748.
DOI: 10.1038/s41598-020-60610-5.
Brown F, Sen D, LaFleur M, Godec J, Lukacs-Kornek V, Schildberg F
Nat Immunol. 2019; 20(12):1668-1680.
PMID: 31636464
PMC: 7464610.
DOI: 10.1038/s41590-019-0515-x.
A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio.
Grimes D, Partridge M
Biomed Phys Eng Express. 2016; 1(4):045209.
PMID: 26925254
PMC: 4765087.
DOI: 10.1088/2057-1976/1/4/045209.
Spherical cancer models in tumor biology.
Weiswald L, Bellet D, Dangles-Marie V
Neoplasia. 2015; 17(1):1-15.
PMID: 25622895
PMC: 4309685.
DOI: 10.1016/j.neo.2014.12.004.
Positron emission tomography to assess hypoxia and perfusion in lung cancer.
Verwer E, Boellaard R, van der Veldt A
World J Clin Oncol. 2014; 5(5):824-44.
PMID: 25493221
PMC: 4259945.
DOI: 10.5306/wjco.v5.i5.824.
Dynamics of tumor hypoxia in response to patupilone and ionizing radiation.
Orlowski K, Rohrer Bley C, Zimmermann M, Vuong V, Hug D, Soltermann A
PLoS One. 2012; 7(12):e51476.
PMID: 23251549
PMC: 3519688.
DOI: 10.1371/journal.pone.0051476.
Radiotherapy in combination with vascular-targeted therapies.
Ciric E, Sersa G
Radiol Oncol. 2012; 44(2):67-78.
PMID: 22933894
PMC: 3423684.
DOI: 10.2478/v10019-010-0025-9.
Effects of irradiation on tumor cell survival, invasion and angiogenesis.
Kargiotis O, Geka A, Rao J, Kyritsis A
J Neurooncol. 2010; 100(3):323-38.
PMID: 20449629
DOI: 10.1007/s11060-010-0199-4.
Enhanced radiation response of a solid tumor with the artificial oxygen carrier 'albumin-heme'.
Horinouchi H, Yamamoto H, Komatsu T, Huang Y, Tsuchida E, Kobayashi K
Cancer Sci. 2008; 99(6):1274-8.
PMID: 18429955
PMC: 11158534.
DOI: 10.1111/j.1349-7006.2008.00811.x.
Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive P, Durand R, Raleigh J, Luo C, Aquino-Parsons C
Br J Cancer. 2000; 83(11):1525-31.
PMID: 11076663
PMC: 2363410.
DOI: 10.1054/bjoc.2000.1489.
Detection of hypoxic cells in murine tumors using the comet assay: comparison with a conventional radiobiological assay.
Shibuya K, Sasai K, Xie X, Utsumi H, Shibata T, Hiraoka M
Jpn J Cancer Res. 1999; 90(8):880-6.
PMID: 10543261
PMC: 5926142.
DOI: 10.1111/j.1349-7006.1999.tb00830.x.
A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines.
Chiarotto J, Hill R
Br J Cancer. 1999; 80(10):1518-24.
PMID: 10408392
PMC: 2363165.
DOI: 10.1038/sj.bjc.6690555.
A dual hypoxic marker technique for measuring oxygenation change within individual tumors.
Iyer R, Kim E, SCHNEIDER R, Chapman J
Br J Cancer. 1998; 78(2):163-9.
PMID: 9683288
PMC: 2062896.
DOI: 10.1038/bjc.1998.459.
Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.
Olive P, Horsman M, Grau C, Overgaard J
Br J Cancer. 1997; 76(6):694-9.
PMID: 9310232
PMC: 2228026.
DOI: 10.1038/bjc.1997.448.
Influence of topoisomerase II on the formation of oxygen-dependent radiation-induced DNA damage.
Zhang H, Wheeler K
Br J Cancer Suppl. 1996; 27:S196-9.
PMID: 8763879
PMC: 2150016.
Heterogeneity in human tumour hypoxic fraction using the comet assay.
Olive P, Trotter T, Banath J, Jackson S, Le Riche J
Br J Cancer Suppl. 1996; 27:S191-5.
PMID: 8763878
PMC: 2149988.
Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
Siim B, Atwell G, Wilson W
Br J Cancer. 1994; 70(4):596-603.
PMID: 7917903
PMC: 2033401.
DOI: 10.1038/bjc.1994.357.
